Medication-assisted treatment (MAT) is an evidence-based method of treating opioid addiction. Of incarcerated individuals in the United States, 50% to 85% have a history of substance abuse, and > 80% of inmates with opioid addiction history do not receive treatment. The purpose of this study was to explore individuals’ experiences after being tapered from MAT upon incarceration.
Methods:
Interpretative phenomenological analysis was employed using in-depth interviewing of 10 participants.
Results:
Analysis identified six themes that captured the essence of the participants’ experiences.
Implications and Conclusion:
Losing MAT upon incarceration was described as an extremely stressful experience for many individuals and may create issues for both inmates and facility staff. Further research is needed to discover ways to improve addiction treatment in prison.
BinswangerI. A., NowelsC., CorsiK. F., GlanzJ., LongJ., BoothR. E., SteinerJ. F. (2012). Return to drug use and overdose after release from prison: A qualitative study of risk and protective factors. Addiction Science and Clinical Practice, 7, 1–9.
2.
CalsynD. A., MalcyJ. A., SaxonA. J. (2006). Slow tapering from methadone maintenance in a program encouraging indefinite maintenance. Journal of Substance Abuse Treatment, 30, 159–163.
3.
ChandlerR. K., FletcherB. W., VolkowN. D. (2009). Treating drug abuse and addiction in the criminal justice system. Journal of the American Medical Association, 301, 183–190.
4.
CropseyK. L., BinswangerI. A., ClarkC. B., TaxmanF. S. (2012). The unmet medical needs of correctional populations in the United States. Journal of the National Medical Association, 104, 487–492.
5.
FiscellaK., MooreA., EngermanJ., MeldrumS. (2004). Jail management of arrestees/inmates enrolled in community methadone maintenance programs. Journal of Urban Health, 81, 645–654.
6.
GordonM. S., KinlockT. W., SchwartzR. P., O’GradyK. E. (2008). A randomized clinical trial of methadone maintenance for prisoners: Findings at 6 months post-release. Addiction, 103, 1333–1342.
7.
HendrichD., AlvesP., FarrellM., StoverH., MollerL., MayetS. (2011). The effectiveness of medication assisted treatment in prison settings: A systematic review. Addiction, 107, 501–517.
8.
McKenzieM., NunnA., ZallerN. D., BazaziA. R., RichJ. D. (2009). Overcoming obstacles to implementing methadone maintenance therapy for prisoners: Implications for policy and practice. Journal of Opioid Management, 5, 219–227.
9.
MumolaC., KarbergJ. (2006). Drug use and dependence, state and federal prisoners, 2004 (NCJ 213530). Washington, DC: Bureau of Justice Statistics.
NosykB., SunH., EvansE., MarshD. C., AnglinM. D., HserY., AnisA. (2012). Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: Results from a population-based retrospective cohort study. Addiction, 107, 1621–1629.
13.
NunnA., ZallerN., DickmanS., TrimburC., NijhawanA., RichJ. D. (2009). Methadone and buprenorphine prescribing and referral practices in U.S. prison systems: Results from a nationwide survey. Drug and Alcohol Dependence, 105, 83–88.
14.
PolitD., BeckC. (2011). Nursing research: Generating and assessing evidence for nursing practice (9th ed.). New York, NY: Wolters Kluwer/Lippincott Williams & Wilkins.
15.
RayM. (1994). The richness of phenomenology: Philosophic, theoretic, and methodological concerns. In MorseJ. (Ed.), Critical issues in qualitative research methods (pp. 116–133). Thousand Oaks, CA: Sage.
